Sonoma Pharmaceuticals, Inc. (SNOA)
1.32
-0.01
(-0.75%)
USD |
NASDAQ |
Sep 09, 16:00
1.32
0.00 (0.00%)
After-Hours: 17:28
Sonoma Pharmaceuticals Total Liabilities (Quarterly) : 11.51M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.51M |
| March 31, 2026 | 10.98M |
| December 31, 2025 | 10.19M |
| September 30, 2025 | 10.07M |
| June 30, 2025 | 10.54M |
| March 31, 2025 | 9.384M |
| December 31, 2024 | 8.798M |
| September 30, 2024 | 8.333M |
| June 30, 2024 | 8.698M |
| March 31, 2024 | 8.756M |
| December 31, 2023 | 7.926M |
| September 30, 2023 | 7.96M |
| June 30, 2023 | 8.651M |
| March 31, 2023 | 8.432M |
| December 31, 2022 | 8.369M |
| September 30, 2022 | 7.941M |
| June 30, 2022 | 9.199M |
| March 31, 2022 | 10.49M |
| December 31, 2021 | 8.178M |
| September 30, 2021 | 8.368M |
| June 30, 2021 | 9.50M |
| March 31, 2021 | 9.624M |
| December 31, 2020 | 5.915M |
| September 30, 2020 | 6.583M |
| June 30, 2020 | 7.418M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.937M |
| December 31, 2019 | 5.287M |
| September 30, 2019 | 5.874M |
| June 30, 2019 | 5.414M |
| March 31, 2019 | 3.959M |
| December 31, 2018 | 3.705M |
| September 30, 2018 | 3.563M |
| June 30, 2018 | 4.004M |
| March 31, 2018 | 3.88M |
| December 31, 2017 | 4.099M |
| September 30, 2017 | 3.993M |
| June 30, 2017 | 3.815M |
| March 31, 2017 | 4.028M |
| December 31, 2016 | 4.644M |
| September 30, 2016 | 3.202M |
| June 30, 2016 | 3.57M |
| March 31, 2016 | 3.663M |
| December 31, 2015 | 2.98M |
| September 30, 2015 | 2.836M |
| June 30, 2015 | 3.069M |
| March 31, 2015 | 2.994M |
| December 31, 2014 | 4.006M |
| September 30, 2014 | 5.024M |
| June 30, 2014 | 6.475M |
| March 31, 2014 | 8.728M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.11M |
| Shareholders Equity (Quarterly) | 6.594M |
| Debt to Equity Ratio | 0.1121 |
| Current Ratio | 2.987 |
| Net Debt Paydown Yield | -1.47% |